Clinical Trial Update: Terlipressin in Septic Shock: Effects on Microcirculation [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating terlipressin for septic shock, focusing on its effects on microcirculation, have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Septic Shock, Sepsis | Phase 2, Phase 3 | Status: COMPLETED